Pediatric Sarcomas: Our Clinical Trials

Through clinical trials, our medical experts evaluate the safety and effectiveness of new therapies and diagnostic tools for pediatric sarcomas. Clinical trials can also help our doctors compare the effectiveness of different aspects of your child’s care, or determine the causes of sarcomas.

If your child is eligible to participate in a clinical trial, he or she may have access to new therapies that are not yet available elsewhere. Our clinical research team is highly experienced in selecting children who are most likely to benefit from a particular investigational therapy. They can guide you through the process of choosing the most appropriate clinical trial for your child’s needs.

Here you can find a list of many of Memorial Sloan-Kettering’s current clinical trials for pediatric sarcomas. To learn more about a study, choose from the list below.

Showing 11 trials
Titlesort icon Investigator
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193]
Wexler, Leonard, MD
A Phase IB/II Study of Imatinib Plus Everolimus in Synovial Sarcoma
[Protocol 10-167]
Keohan, Mary, MD
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183]
Trippett, Tanya, MD
A Phase II Study of Temsirolimus and IGF-1 receptor antibody IMC-A12 in Patients with Metastatic Sarcomas
[Protocol 09-097]
Schwartz, Gary, MD
A Phase II Trial of a KLH-Conjugated Trivalent Ganglioside Vaccine with OPT-821 versus OPT-821 Alone in Metastatic Sarcoma Patients with No Evidence of Disease
[Protocol 08-153]
Carvajal, Richard, MD
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
[Protocol 03-099]
Wexler, Leonard, MD
A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026]
Wexler, Leonard, MD
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091]
Magnan, Heather, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia, MD
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123]
Meyers, Paul, MD
Heart-Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases: A Feasibility Study
[Protocol 11-100]
Wolden, Suzanne, MD